Companies › OBIO
ORCHESTRA BIOMED HLDGS INC (OBIO)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001814114 · EDGAR filings · Updated 2026-07-02
ORCHESTRA BIOMED HLDGS INC (OBIO) has reported institutional ownership of 39.5%, with 65 institutional managers holding positions valued at $98.0M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-01 — Notice of proposed sale filed (Form 144)
- 2026-06-25 — Insider transaction reported (Form 4)
- 2026-06-25 — Insider transaction reported (Form 4)
- 2026-06-25 — Insider transaction reported (Form 4)
- 2026-06-25 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ORCHESTRA BIOMED HLDGS INC has 65 institutional holders and institutional ownership of 39.5%.
Insider activity
Insiders reported 60 transactions (11 buys, 1 sells) across 13 reporting insiders, with a net reported value of $2.36M.
Data flags from SEC filings
Related companies
FENNEC PHARMACEUTICALS INC (FENC) · Sol-Gel Technologies Ltd (SLGL) · PEPGEN INC (PEPG) · KARYOPHARM THERAPEUTICS INC (KPTI) · MEDIWOUND LTD (MDWD) · KORU MEDICAL SYSTEMS INC (KRMD)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.